Research Center Pharmaceutical Engineering

What Research Center Pharmaceutical Engineering does

Research Center Pharmaceutical Engineering (RCPE) is an Austrian non-profit research organization headquartered in Graz and founded in 2008. According to its firmographic description, RCPE operates as a life science research specialist focused on pharmaceutical engineering, with the mission of manufacturing advanced medicines for patients worldwide. The organization employs 101-250 personnel, placing it in the mid-size research-center bracket and indicating a meaningful body of specialized pharmaceutical-process expertise concentrated at a single Austrian site.

As a non-profit entity, RCPE's commercial mechanics are expected to differ from a for-profit CDMO or pharma company. Revenue is most plausibly derived from a combination of public-sector research grants (Austrian national funding, EU programs such as Horizon Europe), industry-sponsored collaborative research, and contract research or process-development engagements with pharmaceutical manufacturers. Its stated patient-population framing and 'worldwide' scope imply downstream beneficiaries across multiple geographies, even though the directly served customer set (pharma companies, research consortia, public agencies) is not enumerated in the available data.

The available source material is unusually thin: the only substantively loaded source consists of a verification/loading page with no company content, and the firm's products, technologies, customer logos, partnership details, financials, and recent strategic activity are not disclosed. This description should therefore be treated as a structured preliminary characterization pending richer primary-source data on RCPE's specific capabilities, projects, and stakeholder relationships.

Name

Research Center Pharmaceutical Engineering

Website

https://rcpe.at

Company type

Private

Founded year

2008

Headcount range

101–250 employees

Short description

Research Center Pharmaceutical Engineering (RCPE) is an Austrian non-profit life sciences research organization in Graz, founded in 2008, with 101-250 employees, focused on pharmaceutical engineering and advanced medicine manufacturing for patient populations worldwide.

Ownership category

akta.pro rank

Product category

Pharmaceutical Research and Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)

akta.pro secondary industry

Clinical Research & Trial Central Laboratories (HLAFAMAL)

Keywords

• Pharmaceutical research
• Drug development
• Medicine manufacturing
• Life science research
• Pharmaceutical engineering

Headquarters

HQ city

Graz

HQ country

Austria

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain

Core offering

Research Center Pharmaceutical Engineering is a life science research organization that manufactures advance medicines for patients worldwide. The company conducts pharmaceutical engineering research and translates that research into advanced medicine manufacturing, operating as a non-profit research center based in Graz, Austria.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical engineering research services Life science and pharmaceutical engineering research delivered to pharmaceutical and healthcare counterparties; conducted by a non-profit research center headquartered in Graz, Austria.
• Advanced medicine manufacturing Manufacturing of advanced medicines for patients worldwide, delivered from the company's Graz, Austria facility as part of its life science research and production operations.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Expansion highlights1 record

Broad incumbents

• Lonza Group: One of the world's largest contract development and manufacturing organizations (CDMOs), offering pharmaceutical process development, formulation, and manufacturing services across small molecules and biologics — directly comparable to RCPE's pharmaceutical engineering mandate but at vastly larger scale.
• Catalent: Global CDMO providing formulation, process development, and drug delivery technologies to pharma and biotech — overlapping with RCPE's pharmaceutical engineering capabilities, particularly in advanced drug delivery and finished dosage forms.
• Boehringer Ingelheim BioXcellence: Contract manufacturing arm of Boehringer Ingelheim offering biopharmaceutical process development and manufacturing — a European-based CDMO comparable to RCPE in serving pharma customers with engineering and process expertise.
• Evonik Industries (Health Care): Specialty chemicals company with a pharmaceutical CDMO business providing formulation, excipients, and contract manufacturing services — comparable in serving pharmaceutical development customers with engineering-driven solutions.
• WuXi AppTec: Global pharmaceutical and medical device R&D service platform offering CRO/CDMO capabilities across discovery, development, and manufacturing — overlaps with RCPE's research and pharmaceutical engineering services.
• Recipharm: European CDMO providing pharmaceutical development and manufacturing services including formulation and process development — comparable to RCPE's pharmaceutical engineering offerings from a contract services perspective.
• Fareva: Global pharmaceutical contract manufacturer offering formulation, development, and manufacturing services across multiple dosage forms — a comparable CDMO peer in pharmaceutical engineering and contract services.
• Thermo Fisher Scientific (Pharma Services): Operates a major pharmaceutical services business through Patheon offering drug development, formulation, and commercial manufacturing — broadly comparable to RCPE's pharmaceutical engineering focus at global scale.
• Samsung Biologics: Global biopharmaceutical CDMO offering process development and manufacturing services — comparable as a large-scale pharmaceutical engineering and contract manufacturing peer, particularly in biologics.

Direct peers

• Aenova Group: European pharmaceutical CDMO offering formulation development, process engineering, and manufacturing of solid, semi-solid, and liquid dosage forms — a closely comparable mid-sized peer to RCPE with similar service scope.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat2 records

Key risks4 records

Key highlights5 records

Customer concentration

• Xx.com/RCPE
• Facebookfacebook.com/RCPEGraz

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Research Center Pharmaceutical Engineering